-o-
glembatumumab
idiospecific
monoclonal
vanucizumab
immunoreactivity
booster dose
ziltivekimab
pozelimab
muromonab
immunobinding
zenocutuzumab
immunoantigen
dinutuximab
retifanlimab
booster shot
sasanlimab
sintilimab
booster injection
solitomab
toripalimab
atezolizumab
heterophile
alloantibody
pidilizumab
gevokizumab
immunosorbing
immunosorbance
monoantibody
radioimmunoprecipitation
brolucizumab
tislelizumab
polytypic
countercorrelated
abagovomab
olaratumab
immunofiltration
-mab
antiidiotypic
ravulizumab
serofast
heteroclitic antibody
cross-reactivity
ABO antibodies
gamma globulin
radioimmunoelectrophoresis
immunocharacterize
xenoimmunization